Leaflet TAMSULOSIN AUROBINDO 400mcg prolonged release capsules

Indicated for: benign prostatic hyperplasia

Route of administration: oral

Substance: tamsulosin (alpha-1 blocker)

ATC: G04CA02 (Genito urinary system and sex hormones | Drugs used in benign prostatic hypertrophy | Alpha-adrenoreceptor antagonists)

Tamsulosin is a medication primarily used to treat symptoms associated with benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate that can cause difficulty urinating. It is an alpha-blocker that relaxes the smooth muscles in the prostate and bladder neck, making it easier to urinate and reducing symptoms such as weak urine flow, frequent urination, or the feeling of incomplete bladder emptying.

Tamsulosin is usually taken once daily, and its effects may be noticeable within a few days or weeks of treatment. It is important to take it as prescribed by a doctor.

Side effects may include dizziness, fatigue, headache, orthostatic hypotension (low blood pressure upon standing), or ejaculation disorders. In rare cases, a condition called 'intraoperative floppy iris syndrome' may occur during cataract surgery. Patients should inform their doctor about tamsulosin use before undergoing such procedures.

General data about TAMSULOSIN AUROBINDO 400mcg

  • Substance: tamsulosin
  • Date of latest medicines list: 01-06-2023
  • Product code: W64286008
  • Concentration: 400mcg
  • Pharmaceutical form: prolonged release capsules
  • Quantity: 30
  • Product type: Generic medicine
  • Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

  • Manufacturer: APL SWIFT SERVICES (MALTA) LIMITED - MALTA
  • Holder: AUROBINDO PHARMA ROMANIA S.R.L. - ROMANIA
  • Number: 10359/2017/08
  • Shelf life: 2 years

Concentrations available for tamsulosin

  • 0.40mg
  • 0.4mg
  • 400mcg